See All Slides - tctmd.com

Slides

Presentation

Efficient Evaluation for TAVR: What Do We Really Need?

Presenter: John Webb

October 29, 2013

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Presentation TCT 2013

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Presenter: Julie Logan

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Presentation TCT 2013

Repair vs. Replacement for Functional MR

Presenter: Robert Guyton

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

Presenter: Paul Sorajja

October 29, 2013

Presentation TCT 2013

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Presenter: Alejandro Fernandez

October 29, 2013

Advertisement

Slides

Efficient Evaluation for TAVR: What Do We Really Need?

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Repair vs. Replacement for Functional MR

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content